ABC | Volume 114, Nº1, Janeiro 2020

Minieditorial Saraiva Precisamos conhecer a geometria do VE em brasileiros? Arq Bras Cardiol. 2020; 114(1):66-67 1. Almeida RCM, Jorge AJL, RosaMLG, Leite AR, CorreiaDMS, Mesquita ET et al. Padrões de Remodelamento Ventricular Esquerdo na Atenção Primária à Saúde. Arq Bras Cardiol. 2020; 114(1):59-65. 2. OktayAA,LavieCJ,MilaniRV,VenturaHO,GillilandYE,ShahS,etal.Current Perspectives on Left Ventricular Geometry in Systemic Hypertension. Prog Cardiovasc Dis . 2016;59(3):235-46. 3. Kannel WB, Gordon T, Offutt D. Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, andmortality in the Framingham study. Ann Intern Med.1969;71(1):89-105. 4. Aurigemma GP, Gottdiener JS, Shemanski L, Gardin J, KitzmanD. Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the cardiovascular health study. J Am Coll Cardiol. 2001;37(4):1042-8. 5. Gardin JM, McClelland R, KitzmanD, Lima JA, BommerW, KlopfensteinHS, et al. M-mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study). Am J Cardiol. 2001;87(9):1051-7. 6. Aro AL, Reinier K, Phan D, Teodorescu C, Uy-Evanado A, Nichols GA, et al. Left-ventricular geometry and risk of sudden cardiac arrest in patients with preserved or moderately reduced left-ventricular ejection fraction. Europace. 2017;19(7):1146-52. 7. Chatterjee S, Bavishi C, Sardar P, Agarwal V, Krishnamoorthy P, Grodzicki T, et al. Meta-analysis of left ventricular hypertrophy and sustained arrhythmias. Am J Cardiol. 2014;114(7):1049-52. 8. Milani RV, Lavie CJ, Mehra MR, Ventura HO, Kurtz JD, Messerli FH. Left ventricular geometry and survival in patients with normal left ventricular ejection fraction. Am J Cardiol. 2006;97(7):959-63. 9. Artham SM, Lavie CJ, Milani RV, Patel DA, Verma A, Ventura HO. Clinical impact of left ventricular hypertrophy and implications for regression. Prog Cardiovasc Dis. 2009;52(2):153-67. 10. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Jr., Drazner MH, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the AmericanCollege of Cardiology Foundation/AmericanHeart Association Task Force on practice guidelines. Circulation. 2013;128(16):e240-e327. 11. Kuch B, Muscholl M, Luchner A, Doring A, Riegger GA, Schunkert H, et al. Gender specific differences in left ventricular adaptation to obesity and hypertension. J HumHypertens. 1998;12(10):685-91. 12. Cuspidi C, Sala C, Negri F, Mancia G, Morganti A. Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies. J HumHypertens. 2012;26(6):343-9. 13. Lavie CJ, Milani RV, Ventura HO, Cardenas GA, Mehra MR, Messerli FH. Disparate effects of left ventricular geometry and obesity on mortality in patients with preserved left ventricular ejection fraction. Am J Cardiol. 2007;100(9):1460-4. 14. Santos M, Shah AM. Alterations in cardiac structure and function in hypertension. Curr Hypertens Rep. 2014;16(5):428. 15. Cuspidi C, Sala C, Lonati L, Negri F, Rescaldani M, Re A, et al. Metabolic syndrome, left ventricular hypertrophy and carotid atherosclerosis in hypertension: a gender-based study. Blood Press. 2013;22(3):138-43. 16. Palmieri V, Bella JN, Arnett DK, Liu JE, Oberman A, Schuck MY, et al. Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) study. Circulation. 2001;103(1):102-7. 17. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1-39. 18. Lavie CJ, Milani RV, Ventura HO, Messerli FH. Left ventricular geometry and mortality in patients >70 years of age with normal ejection fraction. Am J Cardiol. 2006;98(10):1396-9. 19. Velagaleti RS, Gona P, Pencina MJ, Aragam J, Wang TJ, Levy D, et al. Left ventricularhypertrophypatternsand incidenceofheartfailurewithpreserved versus reduced ejection fraction. Am J Cardiol. 2014;113(1):117-22. 20. Khouri MG, Peshock RM, Ayers CR, de Lemos JA, Drazner MH. A 4-tiered classificationof leftventricularhypertrophybasedon leftventriculargeometry: the Dallas heart study. Circ Cardiovasc Imaging. 2010;3(2):164-71. 21. Bang CN, Gerdts E, Aurigemma GP, Boman K, de SG, Dahlof B, et al. Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients. Circ Cardiovasc Imaging. 2014;7(3):422-9. 22. Garg S, de Lemos JA, Ayers C, Khouri MG, Pandey A, Berry JD, et al. Association of a 4-Tiered Classification of LV Hypertrophy With Adverse CV Outcomes in the General Population. JACC Cardiovasc Imaging. 2015;8(9):1034-41. Referências Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 67